Acute intermittent porphyria; Hereditary coproporphyria; Porphyria; Erythropoietic protoporphyria
Porphyria is a group of inherited disorders involving abnormalities in the production of heme pigments (the base material responsible for hemoglobin (red blood cell pigment), myoglobin (reddish muscle cell pigment) and another group of materials called cytochromes.
Porphyrias are characterized by three major findings: photodermatitis (light sensitivity causing rashes), neuropsychiatric complaints, and visceral complaints (such as abdominal pain or cramping).
Causes, incidence, and risk factors
The porphyrias may be inherited as either autosomal dominant (caused by inheriting one abnormal copy of the gene) or autosomal recessive (requires inheritance of two abnormal genes) traits, depending on which type of porphyria is involved. Some types of porphyria begin in early childhood, some at puberty, and others begin during adulthood.
A classical attack of acute porphyria generally begins with colicky abdominal pain (severe), and is then followed by vomiting and constipation. Personality changes may develop during an acute attack, in addition to peripheral paresthesia (numbness and tingling), weakness, paralysis, sensory changes, and muscle pain. Acute attacks can be life-threatening, producing severe electrolyte imbalances, low blood pressure, and shock.
Urine may become red or brown following an attack. Exposure to sunlight can cause reddening, pain, sensations of heat, blistering, and edema in the skin. These lesions heal slowly, often with scarring or pigment changes and can be disfiguring.
- Red urine
- Sensitivity to sunlight
- Blister (bulla) formation on exposure to sunlight
- Skin swelling (edema) on exposure to sunlight
- Crampy abdominal pain (may be extremely severe)
- Pain in the limbs
- Pain in the back
- Personality change
- Numbness or tingling
- Muscle pain
- Muscle weakness or paralysis
Signs and tests
- Loss of deep tendon reflexes
- Electrolyte changes (see chem-20) - hyponatremia
- Decreased kidney function as may be shown by the following tests: o Urinalysis o Serum creatinine o Creatinine clearance o BUN o Serum potassium o Arterial blood gases
- PROTO blood test (measures porphyrins, blood)
- Enzyme assay for: o Uroporphyrinogen decarboxylase o Protoporphyrinogen oxidase o PorphobilinogenPBG deaminase o Coproporphyrinogen oxidase o ALA dehydratase o Uroporphyrinogen III cosynthase o Ferrochelatase
During an acute attack, these treatments can be expected.
- Maintain electrolyte balance
- Monitor blood gasses
- Increase carbohydrate intake (may be IV glucose solutions)
- Pain medication as needed
- Sedation for restlessness and agitation
- Propranolol for hypertension
- Intravenous hematin
- Avoid all alcohol
- Avoid drugs which may precipitate an attack
- High carbohydrate diet
- Avoid sunlight
- Sunscreen (if not contraindicated)
- Avoid skin trauma
- Consider splenectomy
The porphyrias are life-long intermittent illnesses, but with good long-term management, the affected person can expect long problem-free periods.
- Progressive muscleparalysis
- Respiratory failure
Calling your health care provider
Call your health care provider if you have any of the above symptoms suggestive of a porphyria. If you have already been diagnosed with a porphyria, call your health care provider at the first signs of an acute attack.
Genetic counseling may be of benefit to prospective parents with a family history of any type of porphyria.
by Sharon M. Smith, M.D.
All ArmMed Media material is provided for information only and is neither advice nor a substitute for proper medical care. Consult a qualified healthcare professional who understands your particular history for individual concerns.